Cargando…
Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345654/ https://www.ncbi.nlm.nih.gov/pubmed/35937587 http://dx.doi.org/10.1016/j.nefro.2022.07.004 |
_version_ | 1784761477515706368 |
---|---|
author | Nakaya, Aya Kondo, Morihiro Ogura, Eiji Katayama, Yuki Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Kawano, Yuri Arai, Yuka Kobayashi, Mika Kouyama, Airi Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki |
author_facet | Nakaya, Aya Kondo, Morihiro Ogura, Eiji Katayama, Yuki Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Kawano, Yuri Arai, Yuka Kobayashi, Mika Kouyama, Airi Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki |
author_sort | Nakaya, Aya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9345654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93456542022-08-03 Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir Nakaya, Aya Kondo, Morihiro Ogura, Eiji Katayama, Yuki Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Kawano, Yuri Arai, Yuka Kobayashi, Mika Kouyama, Airi Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki Nefrologia Letter to the Editor Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2022-08-03 /pmc/articles/PMC9345654/ /pubmed/35937587 http://dx.doi.org/10.1016/j.nefro.2022.07.004 Text en © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Nakaya, Aya Kondo, Morihiro Ogura, Eiji Katayama, Yuki Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Kawano, Yuri Arai, Yuka Kobayashi, Mika Kouyama, Airi Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir |
title | Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir |
title_full | Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir |
title_fullStr | Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir |
title_full_unstemmed | Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir |
title_short | Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir |
title_sort | treatment of patients with covid-19 on hemodialysis: efficacy of remdesivir |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345654/ https://www.ncbi.nlm.nih.gov/pubmed/35937587 http://dx.doi.org/10.1016/j.nefro.2022.07.004 |
work_keys_str_mv | AT nakayaaya treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT kondomorihiro treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT oguraeiji treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT katayamayuki treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT yoshinoeiko treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT hozumikazuya treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT tagosaori treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT teranishiyuko treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT minamibashiyuki treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT haradamakiko treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT kawanoyuri treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT araiyuka treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT kobayashimika treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT kouyamaairi treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT yoshidakeno treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT shimizushozo treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT ogurakazuma treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT iwashitakatsuaki treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir AT treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir |